Recognized standard
/TR 13121 First edition 2011-05-15
FDA recognition 18-11 · ISO · Nanotechnology
Key facts
| Recognition number | 18-11 |
|---|---|
| Designation | /TR 13121 First edition 2011-05-15 |
| Title | Nanotechnologies - Nanomaterial risk evaluation |
| Standards developer | International Organization for Standardization |
| Specialty area | Nanotechnology |
| Date of entry | Jan 14, 2019 |
| Scope (excerpt) | This Technical Report describes a process for identifying, evaluating, addressing, making decisions about, and communicating the potential risks of developing and using manufactured nanomaterials, in order to protect the health and safety of the public, consumers, workers and the environment. While… |
At a glance
- None Product codes
- 1–9 FDA guidance documents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA-recognized consensus standards
The FDA recognizes voluntary consensus standards that manufacturers can cite in premarket submissions to show conformity with specific requirements.
Source: U.S. Food and Drug Administration (FDA), Recognized Consensus Standards database · Source date: